BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38184591)

  • 1. Triglyceride-glucose index as a suitable non-insulin-based insulin resistance marker to predict cardiovascular events in patients undergoing complex coronary artery intervention: a large-scale cohort study.
    He J; Song C; Yuan S; Bian X; Lin Z; Yang M; Dou K
    Cardiovasc Diabetol; 2024 Jan; 23(1):15. PubMed ID: 38184591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between non-insulin-based insulin resistance indices and cardiovascular events in patients undergoing percutaneous coronary intervention: a retrospective study.
    Zhang Z; Zhao L; Lu Y; Meng X; Zhou X
    Cardiovasc Diabetol; 2023 Jun; 22(1):161. PubMed ID: 37386494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triglyceride-Glucose Index as a Surrogate Marker of Insulin Resistance for Predicting Cardiovascular Outcomes in Nondiabetic Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    J Atheroscler Thromb; 2021 Nov; 28(11):1175-1194. PubMed ID: 33191314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Xiong S; Chen Q; Chen X; Hou J; Chen Y; Long Y; Yang S; Qi L; Su H; Huang W; Liu H; Zhang Z; Cai L
    Cardiovasc Diabetol; 2022 Aug; 21(1):145. PubMed ID: 35932019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus.
    Zhao Q; Cheng YJ; Xu YK; Zhao ZW; Liu C; Sun TN; Zhou YJ
    Cardiovasc Diabetol; 2021 Sep; 20(1):190. PubMed ID: 34537077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High triglyceride-glucose index predicts cardiovascular events in patients with coronary bifurcation lesions: a large-scale cohort study.
    He J; Yuan S; Song C; Song Y; Bian X; Gao G; Dou K
    Cardiovasc Diabetol; 2023 Oct; 22(1):289. PubMed ID: 37891642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.
    Xiong S; Chen Q; Zhang Z; Chen Y; Hou J; Cui C; Cheng L; Su H; Long Y; Yang S; Qi L; Chen X; Liu H; Cai L
    Cardiovasc Diabetol; 2022 Jun; 21(1):115. PubMed ID: 35751060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome.
    Ma X; Dong L; Shao Q; Cheng Y; Lv S; Sun Y; Shen H; Wang Z; Zhou Y; Liu X
    Cardiovasc Diabetol; 2020 Mar; 19(1):31. PubMed ID: 32156279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention.
    Dong S; Zhao Z; Huang X; Ma M; Yang Z; Fan C; Han H; Wang Z; Shi D; Zhou Y
    Cardiovasc Diabetol; 2023 Oct; 22(1):286. PubMed ID: 37891647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention.
    Tao S; Yu L; Li J; Xie Z; Huang L; Yang D; Tan Y; Zhang W; Huang X; Xue T
    Cardiovasc Diabetol; 2023 Nov; 22(1):322. PubMed ID: 38017540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
    Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
    Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three non-insulin-based insulin resistance indexes in predicting the presence and severity of coronary artery disease.
    Wu Z; Cui H; Li W; Zhang Y; Liu L; Liu Z; Zhang W; Zheng T; Yang J
    Front Cardiovasc Med; 2022; 9():918359. PubMed ID: 35966520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between hyperuricemia and insulin resistance surrogates, dietary- and lifestyle insulin resistance indices in an Iranian population: MASHAD cohort study.
    Seifi N; Nosrati M; Koochackpoor G; Aghasizadeh M; Bahari H; Namdar HB; Afkhami N; Darban RA; Azarian F; Ferns GA; Ghayour-Mobarhan M
    Nutr J; 2024 Jan; 23(1):5. PubMed ID: 38172828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High triglyceride-glucose index and stress hyperglycemia ratio as predictors of adverse cardiac events in patients with coronary chronic total occlusion: a large-scale prospective cohort study.
    Song Y; Cui K; Yang M; Song C; Yin D; Dong Q; Gao Y; Dou K
    Cardiovasc Diabetol; 2023 Jul; 22(1):180. PubMed ID: 37454147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-insulin-based insulin resistance indexes in predicting severity for coronary artery disease.
    Zhang Y; Wang R; Fu X; Song H
    Diabetol Metab Syndr; 2022 Dec; 14(1):191. PubMed ID: 36528713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study.
    Wu Z; Liu L; Wang W; Cui H; Zhang Y; Xu J; Zhang W; Zheng T; Yang J
    Cardiovasc Diabetol; 2022 Jul; 21(1):142. PubMed ID: 35906587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of the Triglyceride-Glucose Index on Poor Prognosis in NonDiabetic Patients Undergoing Percutaneous Coronary Intervention.
    Yang J; Tang YD; Zheng Y; Li C; Zhou Q; Gao J; Meng X; Zhang K; Wang W; Shao C
    Front Endocrinol (Lausanne); 2021; 12():710240. PubMed ID: 34489866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the baseline insulin resistance surrogates and their longitudinal trajectories on cardiovascular disease (coronary heart disease and stroke): a prospective cohort study in rural China.
    Wang S; Zhang X; Keerman M; Guo H; He J; Maimaitijiang R; Wang X; Ma R; Guo S
    Front Endocrinol (Lausanne); 2023; 14():1259062. PubMed ID: 38189050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between non-insulin-based insulin resistance indexes and the risk of prehypertension: A cross-sectional study.
    Zhang X; Yu C; Ye R; Liu T; Chen X
    J Clin Hypertens (Greenwich); 2022 May; 24(5):573-581. PubMed ID: 35411676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    Cardiovasc Diabetol; 2020 Jul; 19(1):108. PubMed ID: 32641127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.